Related Experiment Video
Updated: Mar 27, 2026

F1FO ATPase Vesicle Preparation and Technique for Performing Patch Clamp Recordings of Submitochondrial Vesicle Membranes
Published on: May 4, 2013
cAMP regulates the functional activity, coupling efficiency and structural organization of mammalian FOF1 ATP
Domenico De Rasmo1, Loris Micelli2, Arcangela Santeramo2
1Institute of Biomembrane and Bioenergetics, National Research Council, Bari 70124, Italy.
Abstract:
The present study shows that in isolated mitochondria and myoblast cultures depletion of cAMP, induced by sAC inhibition, depresses both ATP synthesis and hydrolysis by the FOF1 ATP synthase (complex V) of the oxidative phosphorylation system (OXPHOS). These effects are accompanied by the decrease of the respiratory membrane potential, decreased level of FOF1 connecting subunits and depressed oligomerization of the complex. All these effects of sAC inhibition are prevented by the addition of the membrane-permeant 8-Br-cAMP. These results show, for the first time, that cAMP promotes ATP production by complex V and prevents, at the same time, its detour to a mitochondrial membrane leak conductance, which is involved in cell death.
Insights
Cyclic AMP (cAMP) is crucial for mitochondrial function. This study reveals that cAMP enhances ATP production by ATP synthase (complex V) and prevents energy loss, protecting cells from death.
Area of Science:
- Mitochondrial biology
- Cellular metabolism
- Biochemistry
Background:
- The role of cyclic AMP (cAMP) in cellular energy metabolism is complex.
- Soluble adenylyl cyclase (sAC) produces cAMP, influencing mitochondrial function.
- Oxidative phosphorylation system (OXPHOS) is central to cellular energy production.
Purpose of the Study:
- To investigate the direct impact of cAMP on ATP synthesis and hydrolysis by mitochondrial ATP synthase (complex V).
- To elucidate the mechanisms by which cAMP influences mitochondrial function and membrane potential.
- To determine if cAMP plays a protective role against mitochondrial dysfunction.
Main Methods:
- Isolated mitochondria and myoblast cultures were used.
- Soluble adenylyl cyclase (sAC) inhibition was employed to deplete cAMP levels.
- ATP synthesis and hydrolysis rates were measured.
- Respiratory membrane potential and FOF1 ATP synthase oligomerization were assessed.
- The effects were evaluated with and without the addition of 8-Br-cAMP.
Main Results:
- Depletion of cAMP by sAC inhibition significantly reduced both ATP synthesis and hydrolysis by FOF1 ATP synthase (complex V).
- These effects were associated with decreased respiratory membrane potential, reduced levels of FOF1 connecting subunits, and impaired complex oligomerization.
- The addition of 8-Br-cAMP fully prevented the detrimental effects of sAC inhibition.
- cAMP was shown to promote ATP production by complex V and prevent its aberrant function as a membrane leak.
Conclusions:
- cAMP plays a critical role in regulating the function of mitochondrial ATP synthase (complex V).
- cAMP promotes efficient ATP production and prevents energy dissipation through mitochondrial membrane leaks.
- These findings highlight a novel mechanism by which cAMP influences cellular energy homeostasis and cell survival.
Related Concept Videos
ATP Synthase: Structure
ATP Synthase: Mechanism
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
The ADP/ATP Carrier Protein

